Laparoscopic radical prostatectomy for high-risk prostate cancer

Area of Science:

• Urology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• High-risk prostate cancer (HRPC) requires effective treatment strategies.
• Laparoscopic radical prostatectomy (LRP) is a minimally invasive approach for prostate cancer.
• Assessing LRP outcomes in HRPC patients is crucial for treatment planning.

Purpose of the Study:

• To evaluate the efficacy and outcomes of laparoscopic radical prostatectomy (LRP) in patients diagnosed with high-risk prostate cancer (HRPC).
• To analyze oncological control, including positive surgical margin (PSM) rates and biochemical recurrence-free survival.
• To assess functional outcomes such as urinary continence and sexual potency post-LRP.

Main Methods:

• Retrospective analysis of 446 HRPC patients undergoing LRP between 2000 and 2013.
• Preoperative staging included MRI, CT, and bone scans.
• Pelvic lymphadenectomy and neurovascular bundle (NVB) preservation techniques were employed.

Main Results:

• A low complication rate (7.6%) and low transfusion rate (0.7%) were observed.
• Biochemical recurrence-free survival was 79.2% at a mean follow-up of 24.9 months.
• High rates of urinary continence (91.8%) and sexual potency (64.4%) were reported in select patient groups.

Conclusions:

• LRP is an effective treatment for HRPC, offering oncological benefits and acceptable functional outcomes.
• The study supports LRP as a comparable alternative to open radical prostatectomy for HRPC.
• LRP can be considered a primary treatment or the first step in multi-modal therapy for HRPC.